您的位置: 首页 > 农业专利 > 详情页

Formulation comprising gefitinib as oral suspension
专利权人:
NATCO PHARMA LTD
发明人:
PARVATANENI DURGA MAHESWARI,PARVATANENI DURGA MAHESWARI,SOMA DEEPTHI,SOMA DEEPTHI,APPADWEDULA VENKATA SATYANARAYANA,APPADWEDULA VENKATA SATYANARAYANA,ADIBHATLA KALI SATYA BHUJANGA RAO,ADIBHATLA KALI S
申请号:
IN1267/CHE/2013
公开号:
IN2013CH01267A
申请日:
2013.03.22
申请国别(地区):
IN
年份:
2015
代理人:
摘要:
A pharmaceutical suspension suitable for oral administration containing an effective amount of gefitinib to improve palatability, ensuring adequate therapeutic levels of drug concentration in comparison to the commercial tablet dosage form and thus patient compliance can be achieved. The invention also relates to a process for the preparation of stable aqueous oral formulation that can be swallowed easily and comprising active ingredient in an effective concentration for the better therapy especially for the monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer or unresectable head and neck cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充